Cognex (NASDAQ:CGNX – Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Cognex to announce earnings of $0.4238 per share and revenue of $292.0970 million for the quarter. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Parties can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.
Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same quarter last year, the firm earned $0.14 earnings per share. The firm’s quarterly revenue was up 24.3% compared to the same quarter last year. On average, analysts expect Cognex to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Cognex Stock Performance
Shares of CGNX opened at $65.24 on Monday. The company has a market cap of $10.86 billion, a price-to-earnings ratio of 77.67 and a beta of 1.49. Cognex has a 12 month low of $34.60 and a 12 month high of $72.88. The business’s fifty day simple moving average is $64.79 and its two-hundred day simple moving average is $56.27.
Cognex Dividend Announcement
Analysts Set New Price Targets
CGNX has been the topic of several research reports. Robert W. Baird set a $72.00 target price on shares of Cognex in a report on Friday, May 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $75.00 target price on shares of Cognex in a report on Thursday, May 7th. UBS Group set a $75.00 price objective on Cognex in a research report on Tuesday, May 26th. Wall Street Zen upgraded shares of Cognex from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $80.00 price target (up from $70.00) on shares of Cognex in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.31.
Get Our Latest Analysis on CGNX
Insider Buying and Selling at Cognex
In related news, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the sale, the insider owned 11,263 shares in the company, valued at approximately $755,184.15. The trade was a 85.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. The trade was a 83.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 224,847 shares of company stock valued at $14,975,098 in the last quarter. 1.70% of the stock is owned by insiders.
Institutional Trading of Cognex
A number of hedge funds have recently bought and sold shares of CGNX. Quadrant Capital Group LLC boosted its holdings in shares of Cognex by 1.0% in the 4th quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after buying an additional 234 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in Cognex by 12.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock worth $68,000 after acquiring an additional 243 shares during the period. Public Employees Retirement System of Ohio boosted its position in Cognex by 0.5% in the third quarter. Public Employees Retirement System of Ohio now owns 54,349 shares of the scientific and technical instruments company’s stock valued at $2,462,000 after buying an additional 292 shares during the last quarter. CIBC Private Wealth Group LLC increased its stake in shares of Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Finally, Snowden Capital Advisors LLC raised its stake in shares of Cognex by 2.0% during the 2nd quarter. Snowden Capital Advisors LLC now owns 17,326 shares of the scientific and technical instruments company’s stock valued at $550,000 after buying an additional 338 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Stories
- Five stocks we like better than Cognex
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
